Non-muscle Invasive Bladder Neoplasms
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-12EMA Authorised: Anktiva (nogapendekin alfa inbakicept) — Immunitybio Ireland Limited
EMA authorised Anktiva (nogapendekin alfa inbakicept) for Non-Muscle Invasive Bladder Neoplasms with conditional approval.